Ignite Creation Date:
2024-05-06 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06186245
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-01-05
First Post:
2023-11-14
Brief Title:
Starvation in the Treatment of Diabetic Ketoacidosis
Sponsor:
Texas Tech University Health Sciences Center
Organization:
Texas Tech University Health Sciences Center
Study Overview
Official Title:
Starvation in the Treatment of Diabetic Ketoacidosis Is There Enough Evidence to Support This Practice
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Diabetic ketoacidosis DKA and hyperosmolar hyperglycemic state HHS are common but serious metabolic disorders are often encountered in intensive care In the intensive care setting it is common to withhold food from patients during treatment of DKA However there is no evidence or current literature supporting this practice The following proposed research investigates the initiation of an early diet versus withholding food during the treatment of diabetic ketoacidosis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None